SITAGLIPTIN

72453 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking SITAGLIPTIN:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 4520
1 NAUSEA 3964
2 DIARRHOEA 3631
3 DRUG INEFFECTIVE 3575
4 FATIGUE 3005
5 HEADACHE 2584
6 DIZZINESS 2508
7 VOMITING 2462
8 DYSPNOEA 2402
9 ACUTE KIDNEY INJURY 2283
See all common reactions for SITAGLIPTIN

SITAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROLOGIC NEGLECT SYNDROME 281 0.5054
1 LUNG DIFFUSION TEST ABNORMAL 46 0.4742
2 BILE DUCT STENT INSERTION 146 0.3822
3 CAROTID ARTERY THROMBOSIS 289 0.3404
4 PNEUMOBILIA 39 0.2349
5 ADJUSTMENT DISORDER 282 0.2169
6 PANCREATICODUODENECTOMY 137 0.2063
7 ADENOCARCINOMA PANCREAS 250 0.1946
8 PANCREATIC CARCINOMA METASTATIC 531 0.1865
9 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 47 0.1521
See all enriched reactions for SITAGLIPTIN